PMID- 25746216 OWN - NLM STAT- MEDLINE DCOM- 20160610 LR - 20151217 IS - 1095-564X (Electronic) IS - 0012-1606 (Linking) VI - 408 IP - 2 DP - 2015 Dec 15 TI - Using Xenopus tissue cultures for the study of myasthenia gravis pathogenesis. PG - 244-51 LID - S0012-1606(15)00087-1 [pii] LID - 10.1016/j.ydbio.2015.02.017 [doi] AB - Myasthenia gravis (MG), the most common autoimmune disease of neuromuscular junction (NMJ), is heterogeneous in terms of pathophysiology, which is determined by the pathogenic antigen of autoantibodies targeting to synaptic proteins at the NMJs. Currently, patients suspected with MG are routinely screened for the presence of autoantibodies against acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) using a cell-based assay (CBA) that involves the expression of target synaptic membrane protein in heterologous cell lines. However, some autoantibodies may only show reactivity for binding to densely clustered AChR in the physiological conformation, while AChR clustering is known to involve signaling events orchestrated by over a dozen of postsynaptic proteins. To improve the existing serological diagnosis of MG, this study explored the possibility of using the well-established Xenopus primary culture system as a novel CBA for MG. Here, by examining the pathogenic effects of four MG human plasma samples, we found that the samples from both seropositive and seronegative MG patients effectively induced the disassembly of aneural AChR clusters in cultured Xenopus muscle cells, as well as the nerve-induced AChR clusters in the nerve-muscle co-cultures. Importantly, the disassembly of AChR clusters was spatio-temporally correlated to the disappearance of actin depolymerizing factor (ADF)/cofilin, an actin regulator involved in AChR trafficking and clustering. Taken together, this study develops a reliable CBA using Xenopus primary cultures for screening the pathogenicity of human MG plasma samples, and providing a platform for investigating the pathogenic mechanisms underlying the endocytic trafficking and degradation of AChRs at NMJs in MG patients. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Yeo, Hwee Li AU - Yeo HL AD - Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore. FAU - Lim, Jorain Yu Ni AU - Lim JY AD - Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore. FAU - Fukami, Yuki AU - Fukami Y AD - Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore. FAU - Yuki, Nobuhiro AU - Yuki N AD - Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore. FAU - Lee, Chi Wai AU - Lee CW AD - Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore. Electronic address: leechiwai@nuhs.edu.sg. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150303 PL - United States TA - Dev Biol JT - Developmental biology JID - 0372762 RN - 0 (Actin Depolymerizing Factors) RN - 0 (Autoantibodies) RN - 0 (Receptors, Cholinergic) RN - EC 2.7.10.1 (MUSK protein, human) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) SB - IM MH - Actin Depolymerizing Factors/metabolism MH - Animals MH - Animals, Genetically Modified MH - Autoantibodies/blood MH - Humans MH - Myasthenia Gravis/*etiology/immunology/metabolism MH - Neuromuscular Junction/immunology/metabolism MH - Receptor Protein-Tyrosine Kinases/immunology/metabolism MH - Receptors, Cholinergic/immunology/metabolism MH - Tissue Culture Techniques MH - Xenopus/embryology/genetics OTO - NOTNLM OT - ADF/cofilin OT - Acetylcholine receptor OT - Cell-based assay OT - Myasthenia gravis OT - Neuromuscular junction OT - Xenopus EDAT- 2015/03/10 06:00 MHDA- 2016/06/11 06:00 CRDT- 2015/03/10 06:00 PHST- 2014/10/31 00:00 [received] PHST- 2015/02/10 00:00 [revised] PHST- 2015/02/20 00:00 [accepted] PHST- 2015/03/10 06:00 [entrez] PHST- 2015/03/10 06:00 [pubmed] PHST- 2016/06/11 06:00 [medline] AID - S0012-1606(15)00087-1 [pii] AID - 10.1016/j.ydbio.2015.02.017 [doi] PST - ppublish SO - Dev Biol. 2015 Dec 15;408(2):244-51. doi: 10.1016/j.ydbio.2015.02.017. Epub 2015 Mar 3.